Double Adenomas of the Pituitary: Transcription Factors Pit-1, T-pit, and SF-1 Identify Cytogenesis and Differentiation

Overview

Journal Endocr Pathol

Specialties Endocrinology
Pathology

Date 2005 Nov 22

PMID 16299401

Citations 19

Authors

R A Jastania

K O Alsaad

M Al-Shraim

K Kovacs

S L Asa

Affiliations

Soon will be listed here.

Abstract

The diagnosis of double adenomas of the pituitary can be very complex and is usually suspected on histological assessment of a specimen and confirmed by immunohistochemical and ultrastructural studies. The most commonly applied technique is currently immunohistochemical staining to localize the six pituitary hormones. Application of this technique may fail to identify double adenomas when hormone immunoreactivity is weak or absent in one or both cell populations. We examined specimens from eight patients diagnosed with double adenomas over a 15-yr period. We tested the ability to detect the difference in the two adenomas in each case using three immunostains for the pituitary transcription factors Pit-1, T-pit, and SF-1. We conclude that immunohistochemical localization of the transcription factors Pit-1, T-pit, and SF-1 accurately detects and classifies the distinct cytodifferentiation of double adenomas of the pituitary.

Citing Articles

Double PitNETs: A Case Report and Literature Review.

Nishiyama M, Fukuhara N, Nishioka H, Yamada S Cancers (Basel). 2025; 17(4).

PMID: 40002269 PMC: 11853428. DOI: 10.3390/cancers17040675.

Plurihormonal Pituitary Neuroendocrine Tumors: Clinical Relevance of Immunohistochemical Analysis.

Dumitriu-Stan R, Burcea I, Dobre R, Nastase V, Ceausu R, Raica M Diagnostics (Basel). 2024; 14(2).

PMID: 38248047 PMC: 10814282. DOI: 10.3390/diagnostics14020170.

The hallmarks of cancer… in pituitary tumors?.

Marrero-Rodriguez D, Taniguchi-Ponciano K, Kerbel J, Cano-Zaragoza A, Remba-Shapiro I, Silva-Roman G Rev Endocr Metab Disord. 2022; 24(2):177-190.

PMID: 36586070 DOI: 10.1007/s11154-022-09777-y.

Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly.

Rymuza J, Kober P, Rusetska N, Mossakowska B, Maksymowicz M, Nyc A Cells. 2022; 11(23).

PMID: 36497102 PMC: 9738119. DOI: 10.3390/cells11233846.

CHST7 Methylation Status Related to the Proliferation and Differentiation of Pituitary Adenomas.

Dong W, Shi W, Liu Y, Li J, Zhang Y, Dong G Cells. 2022; 11(15).

PMID: 35954244 PMC: 9368070. DOI: 10.3390/cells11152400.

References

Puy L, Asa S . The ontogeny of pit-1 expression in the human fetal pituitary gland. Neuroendocrinology. 1996; 63(4):349-55. DOI: 10.1159/000126975. View

Kremer P, Forsting M, Ranaei G, Wuster C, Hamer J, Sartor K . Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma. Acta Neurochir (Wien). 2002; 144(5):433-43. DOI: 10.1007/s007010200064. View

Bodner M, Castrillo J, Theill L, Deerinck T, Ellisman M, Karin M . The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell. 1988; 55(3):505-18. DOI: 10.1016/0092-8674(88)90037-2. View

Pulichino A, Vallette-Kasic S, Couture C, Gauthier Y, Brue T, David M . Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev. 2003; 17(6):711-6. PMC: 196015. DOI: 10.1101/gad.1065603. View

Mazarakis N, Kontogeorgos G, Kovacs K, Horvath E, Borboli N, Piaditis G . Composite somatotroph--ACTH-immunoreactive pituitary adenoma with transformation of hyperplasia to adenoma. Pituitary. 2002; 4(4):215-21. DOI: 10.1023/a:1020764013137. View

Asa S, Bamberger A, Cao B, Wong M, Parker K, Ezzat S . The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab. 1996; 81(6):2165-70. DOI: 10.1210/jcem.81.6.8964846. View

Shen W, Moore C, Ikeda Y, Parker K, Ingraham H . Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade. Cell. 1994; 77(5):651-61. DOI: 10.1016/0092-8674(94)90050-7. View

McKelvie P, McNeill P . Double pituitary adenomas: a series of three patients. Pathology. 2002; 34(1):57-60. DOI: 10.1080/00313020120105651. View

Vidal S, Syro L, Horvath E, Uribe H, Kovacs K . Ultrastructural and immunoelectron microscopic study of three unusual plurihormonal pituitary adenomas. Ultrastruct Pathol. 1999; 23(3):141-8. DOI: 10.1080/019131299281635. View

10.

Asa S, Ezzat S . The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev. 1998; 19(6):798-827. DOI: 10.1210/edrv.19.6.0350. View

11.

Asa S, Kovacs K, Laszlo F, Domokos I, EZRIN C . Human fetal adenohypophysis. Histologic and immunocytochemical analysis. Neuroendocrinology. 1986; 43(3):308-16. DOI: 10.1159/000124545. View

12.

Ma W, Ikeda H, Yoshimoto T . Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas. Cancer. 2002; 95(2):258-66. DOI: 10.1002/cncr.10676. View

13.

Morohashi K, Zanger U, Honda S, Hara M, Waterman M, Omura T . Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BP. Mol Endocrinol. 1993; 7(9):1196-204. DOI: 10.1210/mend.7.9.8247022. View

14.

Asa S, Gerrie B, Singer W, Horvath E, Kovacs K, Smyth H . Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas. J Clin Endocrinol Metab. 1986; 62(5):1011-9. DOI: 10.1210/jcem-62-5-1011. View

15.

Tahara S, Kurotani R, Ishii Y, Sanno N, Teramoto A, Yoshiyuki Osamura R . A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism. Mod Pathol. 2002; 15(10):1102-5. DOI: 10.1097/01.MP.0000030451.28828.00. View

16.

Trouillas J, Seret-Begue D, Kujas M, Delisle M, Ronin C . Evaluation of 29 monoclonal and polyclonal antibodies used in the diagnosis of pituitary adenomas. A collaborative study from pathologists of the Club Français de l'Hypophyse. Pathol Res Pract. 1991; 187(5):534-8. DOI: 10.1016/S0344-0338(11)80136-6. View

17.

Lala D, Rice D, Parker K . Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol. 1992; 6(8):1249-58. DOI: 10.1210/mend.6.8.1406703. View

18.

Syro L, Horvath E, Kovacs K . Double adenoma of the pituitary: a somatotroph adenoma colliding with a gonadotroph adenoma. J Endocrinol Invest. 2000; 23(1):37-41. DOI: 10.1007/BF03343674. View

19.

Kim K, Yamada S, Usui M, Sano T . Preoperative identification of clearly separated double pituitary adenomas. Clin Endocrinol (Oxf). 2004; 61(1):26-30. DOI: 10.1111/j.1365-2265.2004.02055.x. View

20.

Ingraham H, Chen R, Mangalam H, Elsholtz H, FLYNN S, Lin C . A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell. 1988; 55(3):519-29. DOI: 10.1016/0092-8674(88)90038-4. View